APO Research
Talk to an analyst

APO RESEARCH · REPORT

Erectile Dysfunction Drugs

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.

Selected research

Market Outlook & Growth Opportunities

Global Erectile Dysfunction Drugs Market Outlook and Growth Opportunities 2026

19 December 2025194 pages

Choose your research edition.

Industry ResearchErectile Dysfunction Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Erectile Dysfunction Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Erectile Dysfunction Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Erectile Dysfunction Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Erectile Dysfunction Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.

North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.

The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.

Read the full market overview

This report provides an overview of the global Erectile Dysfunction Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Erectile Dysfunction Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Erectile Dysfunction Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Erectile Dysfunction Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Erectile Dysfunction Drugs Segment by Company

Eli Lilly

Pfizer

Bayer

BaiYunShan General Factory

S.K. Chemicals

Teva Pharma

Dong-A ST

Metuchen Pharma

Seoul Pharma

CSBIO.

Erectile Dysfunction Drugs Segment by Type

Sildenafil

Tadalafil

Others

Erectile Dysfunction Drugs Segment by Application

Hospital Pharmacies

Private Clinics

Retail Pharmacies

E-Commerce (B2B)

E-Commerce (B2C)

Erectile Dysfunction Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Erectile Dysfunction Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Erectile Dysfunction Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Erectile Dysfunction Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Erectile Dysfunction Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erectile Dysfunction Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Erectile Dysfunction Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erectile Dysfunction Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Erectile Dysfunction Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Erectile Dysfunction Drugs industry.

Chapter 3: Detailed analysis of Erectile Dysfunction Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Erectile Dysfunction Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Erectile Dysfunction Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Erectile Dysfunction Drugs Industry Trends Table 2. Erectile Dysfunction Drugs Industry Drivers Table 3. Erectile Dysfunction Drugs Industry Opportunities and Challenges Table 4. Erectile Dysfunction Drugs Industry Restraints Table 5. Global Erectile Dysfunction Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Erectile Dysfunction Drugs Revenue Share by Company (2021-2026) Table 7. Global Erectile Dysfunction Drugs Sales Volume by Company (M Pill) & (2021-2026) Table 8. Global Erectile Dysfunction Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Erectile Dysfunction Drugs Average Price (USD/Pill) of Company (2021-2026) Table 10. Global Erectile Dysfunction Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Erectile Dysfunction Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Erectile Dysfunction Drugs Company, Product Type & Application Table 13. Global Erectile Dysfunction Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Erectile Dysfunction Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Sildenafil Table 18. Significant Companies of Tadalafil Table 19. Significant Companies of Others Table 20. Global Erectile Dysfunction Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (M Pill) Table 21. Global Erectile Dysfunction Drugs Sales Volume by Type (2021-2026) & (M Pill) Table 22. Global Erectile Dysfunction Drugs Sales Volume by Type (2027-2032) & (M Pill) Table 23. Global Erectile Dysfunction Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Erectile Dysfunction Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Erectile Dysfunction Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Erectile Dysfunction Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Erectile Dysfunction Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Erectile Dysfunction Drugs Sales Value Share by Type (2021-2026) Table 29. Global Erectile Dysfunction Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Pharmacies Table 31. Significant Companies of Private Clinics Table 32. Significant Companies of Retail Pharmacies Table 33. Significant Companies of E-Commerce (B2B) Table 34. Significant Companies of E-Commerce (B2C) Table 35. Global Erectile Dysfunction Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (M Pill) Table 36. Global Erectile Dysfunction Drugs Sales Volume by Application (2021-2026) & (M Pill) Table 37. Global Erectile Dysfunction Drugs Sales Volume by Application (2027-2032) & (M Pill) Table 38. Global Erectile Dysfunction Drugs Sales Volume Share by Application (2021-2026) Table 39. Global Erectile Dysfunction Drugs Sales Volume Share by Application (2027-2032) Table 40. Global Erectile Dysfunction Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Erectile Dysfunction Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Erectile Dysfunction Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Erectile Dysfunction Drugs Sales Value Share by Application (2021-2026) Table 44. Global Erectile Dysfunction Drugs Sales Value Share by Application (2027-2032) Table 45. Global Erectile Dysfunction Drugs Sales by Region: 2021 VS 2025 VS 2032 (M Pill) Table 46. Global Erectile Dysfunction Drugs Sales by Region (2021-2026) & (M Pill) Table 47. Global Erectile Dysfunction Drugs Sales Market Share by Region (2021-2026) Table 48. Global Erectile Dysfunction Drugs Sales by Region (2027-2032) & (M Pill) Table 49. Global Erectile Dysfunction Drugs Sales Market Share by Region (2027-2032) Table 50. Global Erectile Dysfunction Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Erectile Dysfunction Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Erectile Dysfunction Drugs Sales Value Share by Region (2021-2026) Table 53. Global Erectile Dysfunction Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Erectile Dysfunction Drugs Sales Value Share by Region (2027-2032) Table 55. Global Erectile Dysfunction Drugs Market Average Price (USD/Pill) by Region (2021-2026) Table 56. Global Erectile Dysfunction Drugs Market Average Price (USD/Pill) by Region (2027-2032) Table 57. Global Erectile Dysfunction Drugs Sales by Country: 2021 VS 2025 VS 2032 (M Pill) Table 58. Global Erectile Dysfunction Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Erectile Dysfunction Drugs Sales by Country (2021-2026) & (M Pill) Table 60. Global Erectile Dysfunction Drugs Sales Market Share by Country (2021-2026) Table 61. Global Erectile Dysfunction Drugs Sales by Country (2027-2032) & (M Pill) Table 62. Global Erectile Dysfunction Drugs Sales Market Share by Country (2027-2032) Table 63. Global Erectile Dysfunction Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Erectile Dysfunction Drugs Sales Value Market Share by Country (2021-2026) Table 65. Global Erectile Dysfunction Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Erectile Dysfunction Drugs Sales Value Market Share by Country (2027-2032) Table 67. Eli Lilly Company Information Table 68. Eli Lilly Business Overview Table 69. Eli Lilly Erectile Dysfunction Drugs Sales (M Pill), Value (US$ Million), Price (USD/Pill) and Gross Margin (2021-2026) Table 70. Eli Lilly Erectile Dysfunction Drugs Product Portfolio Table 71. Eli Lilly Recent Development Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Erectile Dysfunction Drugs Sales (M Pill), Value (US$ Million), Price (USD/Pill) and Gross Margin (2021-2026) Table 75. Pfizer Erectile Dysfunction Drugs Product Portfolio Table 76. Pfizer Recent Development Table 77. Bayer Company Information Table 78. Bayer Business Overview Table 79. Bayer Erectile Dysfunction Drugs Sales (M Pill), Value (US$ Million), Price (USD/Pill) and Gross Margin (2021-2026) Table 80. Bayer Erectile Dysfunction Drugs Product Portfolio Table 81. Bayer Recent Development Table 82. BaiYunShan General Factory Company Information Table 83. BaiYunShan General Factory Business Overview Table 84. BaiYunShan General Factory Erectile Dysfunction Drugs Sales (M Pill), Value (US$ Million), Price (USD/Pill) and Gross Margin (2021-2026) Table 85. BaiYunShan General Factory Erectile Dysfunction Drugs Product Portfolio Table 86. BaiYunShan General Factory Recent Development Table 87. S.K. Chemicals Company Information Table 88. S.K. Chemicals Business Overview Table 89. S.K. Chemicals Erectile Dysfunction Drugs Sales (M Pill), Value (US$ Million), Price (USD/Pill) and Gross Margin (2021-2026) Table 90. S.K. Chemicals Erectile Dysfunction Drugs Product Portfolio Table 91. S.K. Chemicals Recent Development Table 92. Teva Pharma Company Information Table 93. Teva Pharma Business Overview Table 94. Teva Pharma Erectile Dysfunction Drugs Sales (M Pill), Value (US$ Million), Price (USD/Pill) and Gross Margin (2021-2026) Table 95. Teva Pharma Erectile Dysfunction Drugs Product Portfolio Table 96. Teva Pharma Recent Development Table 97. Dong-A ST Company Information Table 98. Dong-A ST Business Overview Table 99. Dong-A ST Erectile Dysfunction Drugs Sales (M Pill), Value (US$ Million), Price (USD/Pill) and Gross Margin (2021-2026) Table 100. Dong-A ST Erectile Dysfunction Drugs Product Portfolio Table 101. Dong-A ST Recent Development Table 102. Metuchen Pharma Company Information Table 103. Metuchen Pharma Business Overview Table 104. Metuchen Pharma Erectile Dysfunction Drugs Sales (M Pill), Value (US$ Million), Price (USD/Pill) and Gross Margin (2021-2026) Table 105. Metuchen Pharma Erectile Dysfunction Drugs Product Portfolio Table 106. Metuchen Pharma Recent Development Table 107. Seoul Pharma Company Information Table 108. Seoul Pharma Business Overview Table 109. Seoul Pharma Erectile Dysfunction Drugs Sales (M Pill), Value (US$ Million), Price (USD/Pill) and Gross Margin (2021-2026) Table 110. Seoul Pharma Erectile Dysfunction Drugs Product Portfolio Table 111. Seoul Pharma Recent Development Table 112. CSBIO. Company Information Table 113. CSBIO. Business Overview Table 114. CSBIO. Erectile Dysfunction Drugs Sales (M Pill), Value (US$ Million), Price (USD/Pill) and Gross Margin (2021-2026) Table 115. CSBIO. Erectile Dysfunction Drugs Product Portfolio Table 116. CSBIO. Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Erectile Dysfunction Drugs Distributors List Table 120. Erectile Dysfunction Drugs Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Erectile Dysfunction Drugs Product Image Figure 2. Global Erectile Dysfunction Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Erectile Dysfunction Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Erectile Dysfunction Drugs Sales (2021-2032) & (M Pill) Figure 5. Global Erectile Dysfunction Drugs Sales Average Price (USD/Pill) & (2021-2032) Figure 6. Global Erectile Dysfunction Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Sildenafil Image Figure 10. Tadalafil Image Figure 11. Others Image Figure 12. Global Erectile Dysfunction Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (M Pill) Figure 13. Global Erectile Dysfunction Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Erectile Dysfunction Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Erectile Dysfunction Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Erectile Dysfunction Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Erectile Dysfunction Drugs Sales Value Share by Type (2021-2032) Figure 18. Hospital Pharmacies Image Figure 19. Private Clinics Image Figure 20. Retail Pharmacies Image Figure 21. E-Commerce (B2B) Image Figure 22. E-Commerce (B2C) Image Figure 23. Global Erectile Dysfunction Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (M Pill) Figure 24. Global Erectile Dysfunction Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Erectile Dysfunction Drugs Sales Volume Share by Application (2021-2032) Figure 26. Global Erectile Dysfunction Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Erectile Dysfunction Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Erectile Dysfunction Drugs Sales Value Share by Application (2021-2032) Figure 29. Global Erectile Dysfunction Drugs Sales by Region: 2021 VS 2025 VS 2032 (M Pill) Figure 30. Global Erectile Dysfunction Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Erectile Dysfunction Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Erectile Dysfunction Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Erectile Dysfunction Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. North America Erectile Dysfunction Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Erectile Dysfunction Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Erectile Dysfunction Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Erectile Dysfunction Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Erectile Dysfunction Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Erectile Dysfunction Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. South America Erectile Dysfunction Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Erectile Dysfunction Drugs Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Erectile Dysfunction Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Erectile Dysfunction Drugs Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Erectile Dysfunction Drugs Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Sildenafil
  • Tadalafil
  • Others
Applications
  • Hospital Pharmacies
  • Private Clinics
  • Retail Pharmacies
  • E-Commerce (B2B)
  • E-Commerce (B2C)
Companies covered
  • Eli Lilly
  • Pfizer
  • Bayer
  • BaiYunShan General Factory
  • S.K. Chemicals
  • Teva Pharma
  • Dong-A ST
  • Metuchen Pharma
  • Seoul Pharma
  • CSBIO.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Erectile Dysfunction Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Erectile Dysfunction Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Erectile Dysfunction Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Erectile Dysfunction Drugs Market Dynamics
  1. 2.1 Erectile Dysfunction Drugs Industry Trends
  2. 2.2 Erectile Dysfunction Drugs Industry Drivers
  3. 2.3 Erectile Dysfunction Drugs Industry Opportunities and Challenges
  4. 2.4 Erectile Dysfunction Drugs Industry Restraints
3 Erectile Dysfunction Drugs Market by Company
  1. 3.1 Global Erectile Dysfunction Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Erectile Dysfunction Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Erectile Dysfunction Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Erectile Dysfunction Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Erectile Dysfunction Drugs Company Ranking (2024-2026)
  6. 3.6 Global Erectile Dysfunction Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Erectile Dysfunction Drugs Company Product Type and Application
  8. 3.8 Global Erectile Dysfunction Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Erectile Dysfunction Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Erectile Dysfunction Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Erectile Dysfunction Drugs Market by Type
  1. 4.1 Erectile Dysfunction Drugs Type Introduction
  2. 4.1.1 Sildenafil
  3. 4.1.2 Tadalafil
  4. 4.1.3 Others
  5. 4.2 Global Erectile Dysfunction Drugs Sales Volume by Type
  6. 4.2.1 Global Erectile Dysfunction Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Erectile Dysfunction Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Erectile Dysfunction Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Erectile Dysfunction Drugs Sales Value by Type
  10. 4.3.1 Global Erectile Dysfunction Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Erectile Dysfunction Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Erectile Dysfunction Drugs Sales Value Share by Type (2021-2032)
5 Erectile Dysfunction Drugs Market by Application
  1. 5.1 Erectile Dysfunction Drugs Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Private Clinics
  4. 5.1.3 Retail Pharmacies
  5. 5.1.4 E-Commerce (B2B)
  6. 5.1.5 E-Commerce (B2C)
  7. 5.2 Global Erectile Dysfunction Drugs Sales Volume by Application
  8. 5.2.1 Global Erectile Dysfunction Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Erectile Dysfunction Drugs Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Erectile Dysfunction Drugs Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Erectile Dysfunction Drugs Sales Value by Application
  12. 5.3.1 Global Erectile Dysfunction Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Erectile Dysfunction Drugs Sales Value by Application (2021-2032)
  14. 5.3.3 Global Erectile Dysfunction Drugs Sales Value Share by Application (2021-2032)
6 Erectile Dysfunction Drugs Regional Sales and Value Analysis
  1. 6.1 Global Erectile Dysfunction Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Erectile Dysfunction Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Erectile Dysfunction Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Erectile Dysfunction Drugs Sales by Region (2027-2032)
  5. 6.3 Global Erectile Dysfunction Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Erectile Dysfunction Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Erectile Dysfunction Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Erectile Dysfunction Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Erectile Dysfunction Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Erectile Dysfunction Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Erectile Dysfunction Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Erectile Dysfunction Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Erectile Dysfunction Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Erectile Dysfunction Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Erectile Dysfunction Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Erectile Dysfunction Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Erectile Dysfunction Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Erectile Dysfunction Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Erectile Dysfunction Drugs Sales Value Share by Country, 2025 VS 2032
7 Erectile Dysfunction Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Erectile Dysfunction Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Erectile Dysfunction Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Erectile Dysfunction Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Erectile Dysfunction Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Erectile Dysfunction Drugs Sales by Country (2027-2032)
  6. 7.4 Global Erectile Dysfunction Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Erectile Dysfunction Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Erectile Dysfunction Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Erectile Dysfunction Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Erectile Dysfunction Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Erectile Dysfunction Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eli Lilly
  2. 8.1.1 Eli Lilly Company Information
  3. 8.1.2 Eli Lilly Business Overview
  4. 8.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eli Lilly Erectile Dysfunction Drugs Product Portfolio
  6. 8.1.5 Eli Lilly Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Erectile Dysfunction Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Erectile Dysfunction Drugs Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Erectile Dysfunction Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Erectile Dysfunction Drugs Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 BaiYunShan General Factory
  20. 8.4.1 BaiYunShan General Factory Company Information
  21. 8.4.2 BaiYunShan General Factory Business Overview
  22. 8.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Product Portfolio
  24. 8.4.5 BaiYunShan General Factory Recent Developments
  25. 8.5 S.K. Chemicals
  26. 8.5.1 S.K. Chemicals Company Information
  27. 8.5.2 S.K. Chemicals Business Overview
  28. 8.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 S.K. Chemicals Erectile Dysfunction Drugs Product Portfolio
  30. 8.5.5 S.K. Chemicals Recent Developments
  31. 8.6 Teva Pharma
  32. 8.6.1 Teva Pharma Company Information
  33. 8.6.2 Teva Pharma Business Overview
  34. 8.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Teva Pharma Erectile Dysfunction Drugs Product Portfolio
  36. 8.6.5 Teva Pharma Recent Developments
  37. 8.7 Dong-A ST
  38. 8.7.1 Dong-A ST Company Information
  39. 8.7.2 Dong-A ST Business Overview
  40. 8.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Dong-A ST Erectile Dysfunction Drugs Product Portfolio
  42. 8.7.5 Dong-A ST Recent Developments
  43. 8.8 Metuchen Pharma
  44. 8.8.1 Metuchen Pharma Company Information
  45. 8.8.2 Metuchen Pharma Business Overview
  46. 8.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Metuchen Pharma Erectile Dysfunction Drugs Product Portfolio
  48. 8.8.5 Metuchen Pharma Recent Developments
  49. 8.9 Seoul Pharma
  50. 8.9.1 Seoul Pharma Company Information
  51. 8.9.2 Seoul Pharma Business Overview
  52. 8.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Seoul Pharma Erectile Dysfunction Drugs Product Portfolio
  54. 8.9.5 Seoul Pharma Recent Developments
  55. 8.10 CSBIO.
  56. 8.10.1 CSBIO. Company Information
  57. 8.10.2 CSBIO. Business Overview
  58. 8.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 CSBIO. Erectile Dysfunction Drugs Product Portfolio
  60. 8.10.5 CSBIO. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Erectile Dysfunction Drugs Value Chain Analysis
  2. 9.1.1 Erectile Dysfunction Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Erectile Dysfunction Drugs Sales Mode & Process
  6. 9.2 Erectile Dysfunction Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Erectile Dysfunction Drugs Distributors
  9. 9.2.3 Erectile Dysfunction Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst